St. Jude Draws Warning Letter For Off-label Promotion Of A-Fib Ablation
This article was originally published in The Gray Sheet
Executive Summary
St. Jude Medical has removed Epicor LP cardiac ablation system marketing materials from its website to address a recent FDA warning letter alleging off-label promotion of the device to treat atrial fibrillation